[1]
Vishal, S., Beg, M.A., Dutta, S.B., Khatri, S., Garg, S., Singh, N.K. and Kaur, A. 2017. Comparative evaluation of cost-effectiveness between typical antipsychotic haloperidol and atypical antipsychotics olanzapine, risperidone and aripiprazole in the treatment of stable schizophrenia. International Journal of Basic & Clinical Pharmacology. 6, 8 (Jul. 2017), 1965–1968. DOI:https://doi.org/10.18203/2319-2003.ijbcp20173279.